MyoKardia, Inc. Common Stock
MYOK
MYOK was delisted on the 16th of November, 2020.
73 hedge funds and large institutions have $196M invested in MyoKardia, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 10 closing their positions.
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
69% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 16
3% more funds holding
Funds holding: 71 → 73 (+2)
0% more capital invested
Capital invested by funds: $195M → $196M (+$503K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.29M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.48M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.58M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.51M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$910K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.97M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.04M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.57M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.08M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$869K |
MYOK Hedge Fund Activity: Q1 2017 in Review
73 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q1 2017, worth a combined $196M — up 0.26% from $195M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MYOK positions and 10 closed out — a net gain of 7 holders — while 27 added to existing stakes and 16 trimmed.
The largest buyer was BlackRock, adding an estimated $8.29M. The largest seller was Fidelity Investments, cutting an estimated $7.97M.
- 73 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q1 2017, up from 71 in Q4 2016.
- Funds reported $196M of MyoKardia, Inc. Common Stock stock for Q1 2017, up 0.26% quarter-over-quarter.
- 17 funds opened new MyoKardia, Inc. Common Stock positions in Q1 2017 and 10 closed out, a net change of +7 holders.
- The largest MyoKardia, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $8.29M added.
- The largest MyoKardia, Inc. Common Stock seller in Q1 2017 was Fidelity Investments, an estimated $7.97M sold.
Based on aggregated 13F filings for Q1 2017.